Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01633242 · ClinicalTrials.gov registry record
Heart Imaging in Children With Muscular Dystrophy
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Terminated
- Registry status
- 2
- Enrollment target
NCT01633242: Clinical Trial study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT01633242 is a clinical trial that was terminated before completion, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01633242 was terminated before completion, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Background: \- Muscular dystrophy can affect the muscles used for heart function and breathing. Treatment usually involves drugs that help improve heart function. However, better types of heart imaging studies are needed to improve treatment of heart problems related to muscular dystrophy. Better heart imaging methods are especially needed for children with muscular dystrophy. Researchers want to test different heart imaging methods in children with muscular dystrophy. They will look at cardiac magnetic resonance imaging (MRI) and standard heart function tests. Objectives: \- To develop and test new methods for imaging the heart in children with muscular dystrophy. Eligibility: \- Children and adolescents between 8 and 17 years of age who have muscular dystrophy. Design: * Participants will be screened with a physical exam and medical history. * Participants will provide a blood sample at the start of the study. They will also have heart function tests before having the imaging study. * Participants will have a cardiac MRI scan that will last up to 60 minutes. Some tests will require a MRI contrast agent (a drug that helps the image appear more clearly on the scan).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-02-24 |
| Est. Completion | 2016-10-11 |
Why NCT01633242 stopped before completion
NCT01633242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01633242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01633242 about?
NCT01633242 is a clinical study titled "Heart Imaging in Children With Muscular Dystrophy". Background: \- Muscular dystrophy can affect the muscles used for heart function and breathing. Treatment usually involves drugs that help improve heart function. However, better types of heart imaging studies are needed to improve treatment of heart problems related to muscular dystrophy. Better h...
What is the current status of trial NCT01633242?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2012-02-24. Estimated completion is 2016-10-11.
Who is sponsoring clinical trial NCT01633242?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI